Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Fármaco antiviral altamente eficiente con función inductora de interferón

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TORU20140616001
Publicado:
24/06/2015
Caducidad:
30/12/2015
Resumen:
Una pyme rusa ha desarrollado una sustancia farmacéutica original con acción antiviral de alta eficiencia y función inductora de interferón. El fármaco puede emplearse para el tratamiento y profilaxis de la gripe e infecciones respiratorias, incluyendo bronquitis y neumonía. También puede aplicarse para la profilaxis de complicaciones y normalización de la función fagocítica en pacientes con enfermedades respiratorias graves. Se buscan socios para llevar a cabo actividades de investigación conjunta y ensayos clínicos en el marco de un acuerdo de cooperación técnica, I+D o joint venture.

Details

Tittle:
Highly efficient antiviral drug with interferon inducer function
Summary:
An innovative SME from Kaluga region developed an original pharmaceutical substance with an efficient antiviral action and interferon inducer function. The company is looking for partners for joint research and clinical tests in the framework of technical and/or R&D cooperation, joint venture.
Description:
An innovative SME from Kaluga region developed an original pharmaceutical substance and an antiviral drug based on it. The developed substance is an efficient low-toxic preparation with a direct antiviral action that has an interferon inducer function. The drug can be used for treatment and prophylactics of flu and other respiratory infections, including complicated bronchitis and pneumonia. The drug can also be applied for prophylactics of complications and normalization of phagocyte function in patients with acute respiratory diseases.
The drug works at the early stage of the virus reproduction; it inhibits the fusion of the virus shell with the lipid membrane of the cell, thus preventing the penetration of the virus into the cell. Also, the drug demonstrates the function of interferon inducing agent, it stimulates the antibody response, enhances the phagocyte function and improves the general resistance of the body to viral infections.
The authors are looking for partners for joint research and clinical tests, with the purpose of further organization of the drug production.
Advantages and Innovations:
Preliminary pre-clinical tests showed a higher efficiency of the drug, as compared to analogs. The drug works at the early stage of the disease, inhibiting the fusion of the virus shell with the lipid membrane of the cell, and thus preventing the penetration of the virus into the cell and the cell's lesion.
Beside of the antiviral action, the drug has also an immunomodulating effect, it promotes the interferon production and improves the general resistance of the body to viral infections.
Stage of Development:
Under development/lab tested
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
RF Patent, 2012

Partner sought

Type and Role of Partner Sought:
R&D centre, university or a big pharma company with own research facilities (Pharmaceutics, biotechnology, virology, drug development)

Tasks to be performed: Joint further development, clinical test with the purpose of bringing new medicinal preparations to the market.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English

Keywords

Technology Keywords:
06001002 Investigaciones clínicas, ensayos
06001015 Productos farmacéuticos / medicamentos
06001018 Virus, virología / antibióticos / bacteriología